Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Burkitt Lymphoma 22Dendritic Cell Sarcoma, Interdigitating 21Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 19Lymphoma, B-Cell, Marginal Zone 19Lymphoma, Follicular 18Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 18Sarcoma 17Lymphoma, Large-Cell, Immunoblastic 17Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Acute 17Recurrence 16Hodgkin Disease 16Leukemia 15Myelodysplastic Syndromes 14Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Neuroectodermal Tumors, Primitive, Peripheral 11Neuroblastoma 11Multiple Myeloma 11Congenital Abnormalities 11Sarcoma, Ewing 10Myeloproliferative Disorders 10Waldenstrom Macroglobulinemia 9Rhabdomyosarcoma 9Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Blast Crisis 9

Interventions

montanide ISA 51 1Tumor Necrosis Factor-alpha 1Melphalan 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Neoplasms × Melphalan × Sarcoma × Clear all
NCT00019968 2023-10-31

Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Sarcoma

Neoplasms, Sarcoma, Muscle Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡